Events
Conferences, congresses and webinars where Philogen presents its science.
Philogen to attend the International Controlled Release Congress in Bologna (Italy) on July 9, 2024
Prof. Dario Neri gave a duet lecture entitled: “Nanomedicines, antibodies and imaging for cancer therapy”
Philogen to attend iNano at the University of Aarhus in Aarhus (Denmark) on October 31, 2024
Prof. Dario Neri gave a presentation on “Tumor targeting”
Philogen to attend a lecture at the Department of Chemistry, University of Cambridge in Cambridge (UK) on March 31, 2025
Prof. Dario Neri will give a presentation entitled: “DNA-encoded chemical libraries”
Philogen to attend a lecture at the Gulbenkian Institute of Molecular Medicine (GIMM) in Lisbon (Portugal) on January 20, 2025
Prof. Dario Neri gave a presentation entitled: “From encoded chemical libraries to clinical-stage targeted therapeutics”
Philogen to attend the ESMO-ImmunoOncology (ESMO-IO) Congress 2024 in Geneva (Switzerland) on December 13, 2024
Prof. Dario Neri gave a presentation on “Armed antibodies”
Philogen to attend World ADC on March 3-6, 2025
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted small molecule therapeutics on March 5 (main session), entitled “Detailing Clinical…
Prof. Dario Neri to give a lecture at the University of Milan (Italy) on February 19, 2024
The lecture given at the PhD Course in Pharmaceutical Sciences was entitled: “Encoded combinatorial libraries: from ligand discovery to targeted therapeutics”
Philogen to attend the Novo Nordisk Foundation Symposium on Chemical Biology: from Molecules to Medicine in Copenhagen (Denmark) on June 7, 2024
Prof. Dario Neri gave a presentation entitled: “From encoded combinatorial libraries to clinical-stage targeted therapeutics”
Philogen to attend the ZKB Investors Event in Lausanne (Switzerland) on December 11, 2024
Prof. Dario Neri gave a presentation entitled: “Radiopharmaceuticals: an emerging class of anticancer drugs”
Philogen to attend the 51st ADF Tagung in Berlin (Germany) on March 14, 2025
Prof. Dario Neri will give a keynote lecture entitled: “Tumor targeting in skin cancer and beyond”
Philogen to attend the 12th International Congress on Encoded Combinatorial Libraries in Shanghai (China) on October 12, 2024
Prof. Dario Neri gave the Opening Lecture entitled: “DNA-encoded chemical libraries: past, present and future”
Philogen to attend the Swiss Radiopharmacy Day on March 21, 2025
Our certified radiation protection experts, Dr. Jacqueline Mock and Dr. Sebastian Oehler, will take part and represent Philochem in the Swiss Radiopharmacy Day.
Philogen to attend the Immuno-Oncology Summit Europe in London (UK) on April 25, 2024
Prof. Dario Neri gave a presentation entitled: “Antibody-cytokine fusions directed against splice variants of fibronectin: from discovery to advanced clinical…
Philogen to attend the 10th ImmunoTherapy of Cancer (ITOC) Congress in Munich (Germany) on March 21, 2024
Prof. Dario Neri gave a presentation on Immunocytokines.
Philogen is pleased to invite you to a new webinar on December 9, 2024, at 15:00 GMT | 16:00 CET.
Management will present the financial results and provide an update on the industrial programs. Please contact us at IR@philogen.com or follow the link to…
Philogen is pleased to invite you to a new webinar on October 1, 2024, at 15:00 GMT | 16:00 CET.
Management will present the financial results and provide an update on the industrial programs. Please contact us at IR@philogen.com or follow the link to…
Philogen to attend the European Association of Nuclear Medicine (EANM) annual meeting on October 19-23, 2024
Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of…
Philogen to attend the EFMC ISMC 2024 on September 4, 2024 in Rome
Dr. Samuele Cazzamalli is giving a presentation entitled “DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands and for the…
Philogen to attend PEGS2024 on September 6, 2024 in Barcelona
Prof. Dr. Dario Neri, Philogen’s CEO and CSO, is giving a lecture entitled “Antibody-Cytokine Fusion Proteins for Cancer Therapy: Late-Stage Clinical Results”…
Philogen is pleased to invite you to a new webinar on July 10, 2024, at 14:00 GMT | 15:00 CET.
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please…
Philochem to attend the 72nd ASMS Conference on Mass Spectrometry and Allied Topics in Anaheim on June 2-6, 2024
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will attend the 72nd ASMS conference in Anaheim (2-6 June 2024) and present a poster entitled: “Mass…
Philogen to attend the SNMMI Annual Meeting in Toronto on June 8-11, 2024
Dr. Andrea Galbiati is giving a presentation about Philochem’s FAP ligand platform on June 9th, entitled “Development of Multivalent OncoFAP Derivatives for the…
Philogen to attend the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024.
The conference provides an opportunity for investors to learn about Philogen’s progress and to meet CEO/CSO Prof. Dario Neri through a series of one-on-one…
Philogen to attend the ASCO congress in Chicago on May 30-31, June 1-3, 2024
Prof. Dr. Axel Hauschild, on behalf of Philogen, is giving a presentation about the Phase III PIVOTAL study on May 31st, entitled “Phase 3 study (PIVOTAL) of…
Philochem to attend as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini on September 18-20, 2024
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will participate as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini with a presentation…
Philogen is delighted to invite you to attend a virtual briefing on April 3, 2024 to discuss the Company’s Full Year 2023 Results.
Management will host a 1-hour live webcast and conference call on April 3, 2024 at 10:00 ET / 15:00 BST / 16:00 CET. The presentation will be followed by a Q&A…
Philogen to attend the Italian Mid Cap Conference organised by Mediobanca on January 23-24, 2024
The Italian Midcap Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri and CFO Laura Baldi…
Philogen to attend the ESMO TAT congress in Paris on February 26-28, 2024
Prof. Dr. Giuseppe Curigliano, on behalf of Philogen, is giving a presentation about the Phase I DODEKA study on February 26th, entitled “Phase I…